Drugs / Neutrolin
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT02651428 | Dec 2015 → Oct 2018 | chronic renal failure syndrome, prosthesis-related infectious disease | CorMedix | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03425448 | Apr 2019 → Oct 2020 | — | King Abdullah International Medical Research Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neutrolin | “Neutrolin catheter locking agent comprises of heparin,citrate and trauolidine” NCT03425448 ↗ |
| Route | Other | “Neutrolin® will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session” NCT02651428 ↗ |